News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xtrana, Inc. (XTRN) Announces Termination Of Merger Discussions With Aduromed Corporation


10/19/2005 5:10:08 PM

Xtrana, Inc. (OTCBB: XTRN) announced today that it has terminated the previously announced negotiations with Aduromed Corporation regarding a potential business combination between the two companies. Xtrana determined to end negotiations and terminate the non-binding letter of intent with Aduromed as result of Xtrana's due diligence investigation of Aduromed and its business.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES